Search - tctmd.com

Displaying 381 - 400 of 827

Sort: Relevancy | Date

News Daily News

Moderate Aortic Stenosis and HFrEF Combo Portends Poor Survival, Study Finds

L.A. McKeown

June 03, 2021

News Opinion CV Team Dispatch

June 2021 News Roundup

L.A. McKeown

June 01, 2021

News Daily News

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

Shelley Wood

May 27, 2021

News Conference News ACC 2021

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Michael O'Riordan

May 25, 2021

News Conference News ACC 2021

Omecamtiv Mecarbil Has Biggest Benefit at Lowest EFs

Todd Neale

May 18, 2021

News Conference News ACC 2021

RAFT-AF: No Benefit of AF Ablation for Heart Failure Patients

Todd Neale

May 17, 2021

News Conference News ACC 2021

REHAB-HF: Tailored Cardiac Rehab Promotes Physical Function After Hospital Stay

Caitlin E. Cox

May 16, 2021

News Conference News ACC 2021

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Yael L. Maxwell

May 16, 2021

News Conference News ACC 2021

PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI

L.A. McKeown

May 15, 2021

News Daily News

AI-ECG Allows for Early Diagnosis of Low EF

Yael L. Maxwell

May 10, 2021

News Conference News SCAI 2021

ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later

Michael O'Riordan

May 06, 2021

News Daily News

FDA Approves Dapagliflozin for CKD Patients

Michael O'Riordan

May 03, 2021

News Daily News

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

Michael O'Riordan

April 26, 2021

News Daily News

Pneumonia in HF Patients Is Common, Lethal, and Preventable

L.A. McKeown

April 19, 2021

News Daily News

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

Michael O'Riordan

April 15, 2021

News Features

AI in Cardiology: Where We Are Now and Where to Go Next

Yael L. Maxwell

March 30, 2021

News Daily News

No Gravity, Smaller Hearts: LV Mass Declines in Space and Water

Michael O'Riordan

March 29, 2021

News Daily News

Patient-Reported Outcomes Beat NYHA Class for Tracking Gains in HFrEF

L.A. McKeown

March 25, 2021

News Daily News

Women Treated for Acute HF Report Worse QoL Than Men

Caitlin E. Cox

March 12, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2021

Shelley Wood

March 02, 2021

Advertisement

Moderate Aortic Stenosis and HFrEF Combo Portends Poor Survival, Study Finds

June 2021 News Roundup

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Omecamtiv Mecarbil Has Biggest Benefit at Lowest EFs

RAFT-AF: No Benefit of AF Ablation for Heart Failure Patients

REHAB-HF: Tailored Cardiac Rehab Promotes Physical Function After Hospital Stay

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI

AI-ECG Allows for Early Diagnosis of Low EF

ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later

FDA Approves Dapagliflozin for CKD Patients

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

Pneumonia in HF Patients Is Common, Lethal, and Preventable

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

AI in Cardiology: Where We Are Now and Where to Go Next

No Gravity, Smaller Hearts: LV Mass Declines in Space and Water

Patient-Reported Outcomes Beat NYHA Class for Tracking Gains in HFrEF

Women Treated for Acute HF Report Worse QoL Than Men

TCTMD’s Top 10 Most Popular Stories for February 2021

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content